Immunome, Inc. (NASDAQ:IMNM) Receives Average Rating of “Buy” from Analysts
Shares of Immunome, Inc. (NASDAQ:IMNM – Get Free Report) have been given an average rating of “Buy” by the six analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock […]
Shares of Immunome, Inc. (NASDAQ:IMNM – Get Free Report) have been given an average rating of “Buy” by the six analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock […]
